Difetarsone
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101652This classification denotes an antiprotozoal agent with the molecular formula C14H18As2N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G4G9J3Q65W, chemically known as n,n-ethylenediarsanilic acid but generally known as difetarsone, which bears US NIH Compound Identifier 68199. European Medicines Agency schedules Difetarsone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07124MIG. The term DIFETARSONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules difetarsone in its Anatomical Therapeutic Chemical (ATC) Classification. DIFETARSONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, DIFETARSONE remains the US FDA Preferred Term for this commodity. Difetarsone bears US NLM identifiers UMLS ID C1322006 and NCI Concept Code C78101. SMILES: [AS](=O)(O)(O)C1CCC(NCCNC2CCC([AS](=O)(O)O)CC2)CC1.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.